The primary endpoint combined death and organ dysfunction
The placebo-controlled LOVIT trial randomized 872 adults with sepsis who needed vasopressor support. Vitamin C or matched placebo was infused repeatedly for up to 96 hours. [1]
Death or persistent organ dysfunction at day 28 occurred in 44.5% of analyzed vitamin C recipients and 38.5% of controls. The risk ratio was 1.21, with a confidence interval excluding no difference. [1]
Report the composite without overstating its components
Death alone was numerically more frequent with vitamin C, but its confidence interval included no difference. The statistically significant finding concerned the combined primary endpoint. [1]
The Lotte and John Hecht Memorial Foundation funded the trial; detailed conflicts were not established from the abstract. These results concern critically ill adults and an intravenous regimen, not ordinary dietary vitamin C. They do not support adding high-dose infusions as a general sepsis treatment based on antioxidant reasoning. [1]
Name the outcome that reached significance
Imagine a combined death-or-organ-dysfunction outcome differs between groups. Reporting that as a separately proven increase in each component would misstate the analysis.
| Detail | Interpretation |
|---|---|
| 872 randomized | Large clinical trial |
| Day-28 composite | Higher risk with vitamin C |
| Food intake | Not the tested exposure |

Sources for this article
- Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.